HPS Pharmacies wish to give notice that Aspen Pharmacare Australia Pty Ltd is continuing to experience a supply interruption for local anaesthetic products.
The following non-autoclaved products are now available, as follows:
|Marcain 0.25% with Adrenaline 5x20mL||125878||In stock – short dated|
|Marcain 0.5% with Adrenaline 5x20mL||48329||In stock – short dated / constrained supply|
|Xylocaine 1% with Adrenaline 5x20mL||12015||In stock – short dated|
|Xylocaine 2% with Adrenaline 5x20mL||12021||In stock – short dated|
Aspen has now received approval from the Therapeutic Goods Administration (TGA) to allow the sterilisation process to be carried out on their products. Distribution of the following Sterile Theatre Packs is expected to resume, as follows:
|Marcain 0.25% with Adrenaline 1:400,000 5x20mL (theatre pack)||125878||Quarter 3, 2023|
|Marcain 0.5% with Adrenaline 1:200,000 5x20mL (theatre pack)||48329||Quarter 3, 2023|
|Xylocaine 2% Adrenaline 1:200,000 5X20mL (theatre pack)||12021||Quarter 3, 2023|
|Xylocaine 1% Adrenaline 1:200,000 5X20mL (theatre pack)||12015||Quarter 3, 2023|
|Xylocaine 0.5% Adrenaline 1:200,000 5X20mL (theatre pack)||12008||Quarter 3, 2023|
In addition, normal supplies of Citanest 0.5% (prilocaine hydrochloride 250mg/50mL) vials are expected to return in late April to early May 2023. All other Aspen local anaesthetic products are available.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Aspen Pharmacare Australia on 1300 659 646.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates